Article
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Journal of physiology and biochemistry - 1 Jun 2010
Basic Jelena, Pavlovic Dusica, Jevtovic-Stoimenov Tatjana, Vojinovic Jelena, Susic Gordana, Stojanovic Ivana, Kocic Gordana, Milosevic Vuk, Cvetkovic Tatjana, Marinkovic Milena, Veljkovic Andrej
Abstract excerpt
Genetic contribution of tumor necrosis factor polymorphism (TNF-alpha-308G/A) in patients with juvenile idiopathic arthritis (JIA) on response to TNF blocking agents, as well as matrix metalloproteinase-9 (MMP-9) production, is not yet well established. We have investigated whether the TNF-alpha-308G/A polymorphism can influence MMP-9 level and clinical response to etanercept (TNF receptor II-Fc fusion protein)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
